Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection.
Jonas MM, Romero R, Rosenthal P, Lin CH, Verucchi G, Wen J, Balistreri WF, Whitworth S, Bansal S, Leung DH, Narkewicz MR, Gonzalez-Peralta RP, Mangia A, Karnsakul W, Rao GS, Shao J, de Jong J, Parhy B, Osinusi A, Kersey K, Murray KF, Sokal EM, Schwarz KB.
Jonas MM, et al. Among authors: whitworth s.
J Pediatr Gastroenterol Nutr. 2024 Jun;78(6):1342-1354. doi: 10.1002/jpn3.12045. Epub 2024 Apr 21.
J Pediatr Gastroenterol Nutr. 2024.
PMID: 38644678
Clinical Trial.